SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN)
AMZN 220.28-1.0%1:04 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GST who wrote (98985)4/5/2000 12:15:00 PM
From: H James Morris  Read Replies (2) of 164684
 
>to the coming meltdown
Coming meltdown?? I'm looking at wonderful buying opportunities like bio-techs... they've been crushed enough...so the elephants are feeding again.
Bought Cra @ 70, but my favorite is Amgn...
>LARCHMONT, N.Y.--(BW HealthWire)--April 4, 2000--Genetic Engineering News' (GEN) 100 "Molecular Millionaires" own a record $7.23 billion in biotechnology stock this year as compared to previous listings.

The total number of millionaires holding a doctoral degree, 96 out of 100, also set a new record, according to the April 1, 2000 issue of GEN (www.genengnews.com).

"This year's edition of Molecular Millionaires demonstrates vividly that biotechnology has finally fulfilled the predictions of many Wall Street analysts over the past decade," says John Sterling, managing editor of GEN. "Along with businesses involved with the internet and telecommunications, biotechnology is poised to become one of the key industries of the future."

William K. Bowes, Jr., is the top millionaire, with $686,398,793 of stock in Amgen (Nasdaq:AMGN), Lynx Therapeutics (Nasdaq:LYNX) and Xoma (Nasdaq:XOMA). He is followed by Phillip Frost, M.D., with $642,434,166 of Ivax (AMEX:IVX); David M. Goldenberg, M.D., Sc.D., $415,064,144 in Immunomedics (Nasdaq:IMMU); Lindsay A. Rosenwald, M.D., $336,387,890 in Avax (Nasdaq:AVXT), Biocryst (Nasdaq:BCRX), Genta (Nasdaq:GNTA), Interneuron (Nasdaq:IPIC) and Neose (Nasdaq:NTEC); Gordon Binder, $308,447,899 in Amgen (Nasdaq:AMGN); and William A. Haseltine, Ph.D., $284,014,797 in Human Genome Sciences (Nasdaq:HGSI).

Compared to the $7.23 billion of stock owned in 2000, stock holdings in previous years included $1.41 billion in 1999, $1.76 billion in 1998, $1.97 billion in 1997 and $2.05 billion in 1996. The total number of doctoral millionaires was 89 last year, 69 in 1998 and 72 in 1997.

Genetic Engineering News is published 21 times a year by Mary Ann Liebert, Inc. For a copy of the listing of Molecular Millionaires, please see our web page at www.genengnews.com or call 914/834-3100, ext. 623, or email: ebicovny@liebertpub.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext